Ladenburg Thalmann Financial Services’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $862K | Sell |
49,430
-12,445
| -20% | -$217K | 0.01% | 1388 |
|
2019
Q3 | $934K | Buy |
61,875
+13,400
| +28% | +$202K | 0.01% | 1294 |
|
2019
Q2 | $818K | Sell |
48,475
-12,882
| -21% | -$217K | 0.01% | 1364 |
|
2019
Q1 | $1.05M | Buy |
61,357
+5,446
| +10% | +$93.3K | 0.01% | 1158 |
|
2018
Q4 | $845K | Buy |
55,911
+1,001
| +2% | +$15.1K | 0.01% | 1156 |
|
2018
Q3 | $1.12M | Sell |
54,910
-1,924
| -3% | -$39.3K | 0.01% | 1053 |
|
2018
Q2 | $1.09M | Hold |
56,834
| – | – | 0.01% | 1019 |
|
2018
Q1 | $1.09M | Sell |
56,834
-1,331
| -2% | -$25.6K | 0.01% | 1019 |
|
2017
Q4 | $1.14M | Buy |
58,165
+2,448
| +4% | +$48.1K | 0.01% | 990 |
|
2017
Q3 | $1.2M | Buy |
55,717
+2,531
| +5% | +$54.4K | 0.01% | 882 |
|
2017
Q2 | $1.11M | Buy |
53,186
+2,230
| +4% | +$46.5K | 0.01% | 884 |
|
2017
Q1 | $988K | Buy |
50,956
+619
| +1% | +$12K | 0.01% | 905 |
|
2016
Q4 | $855K | Buy |
50,337
+1,931
| +4% | +$32.8K | 0.01% | 923 |
|
2016
Q3 | $907K | Buy |
48,406
+2,215
| +5% | +$41.5K | 0.01% | 850 |
|
2016
Q2 | $794K | Sell |
46,191
-2,933
| -6% | -$50.4K | 0.01% | 868 |
|
2016
Q1 | $881K | Sell |
49,124
-589
| -1% | -$10.6K | 0.02% | 762 |
|
2015
Q4 | $1.18M | Buy |
49,713
+1,005
| +2% | +$23.8K | 0.02% | 613 |
|
2015
Q3 | $1.1M | Buy |
48,708
+32,174
| +195% | +$724K | 0.02% | 593 |
|
2015
Q2 | $466K | Buy |
16,534
+6,082
| +58% | +$171K | 0.01% | 1084 |
|
2015
Q1 | $288K | Buy |
10,452
+932
| +10% | +$25.7K | 0.01% | 1339 |
|
2014
Q4 | $237K | Buy |
9,520
+2,162
| +29% | +$53.8K | 0.01% | 1310 |
|
2014
Q3 | $163K | Buy |
7,358
+27
| +0.4% | +$598 | ﹤0.01% | 1324 |
|
2014
Q2 | $152K | Buy |
7,331
+27
| +0.4% | +$560 | ﹤0.01% | 1349 |
|
2014
Q1 | $159K | Buy |
7,304
+387
| +6% | +$8.43K | ﹤0.01% | 1254 |
|
2013
Q4 | $141K | Buy |
6,917
+108
| +2% | +$2.2K | ﹤0.01% | 1253 |
|
2013
Q3 | $131K | Buy |
6,809
+94
| +1% | +$1.81K | ﹤0.01% | 1231 |
|
2013
Q2 | $120K | Buy |
+6,715
| New | +$120K | ﹤0.01% | 1225 |
|